Insights

US Market Expansion bNovate recently expanded its US offices and signed an agreement with Best Water Science to scale real-time water monitoring in the United States, signaling strong go-to-market momentum in North America. This creates sales opportunities with US water utilities, pharmaceutical QA labs, and contract manufacturers for BactoSense instruments and BactoCloud services.

Cloud Platform Growth The launch of BactoCloud connects BactoSense instruments to a secure cloud platform, enabling real-time monitoring and optimization of microbial water quality. This opens upsell opportunities to utilities and pharma customers seeking remote monitoring, data analytics, and scalable service contracts; highlight integration with existing IT and security standards.

Product Portfolio BactoSense portfolio includes CORE, SMART, PURE and an Active Cells UV cartridge, providing tiered solutions for drinking water and pharmaceutical environments. This enables targeted sales motions from cost-conscious customers to advanced digital monitoring programs, with cross-sell into BactoCloud for data access and alerting.

Global Partnerships Strategic collaborations with Best Water Science, ProDetec, and Hamad Bin Khalifa University position bNovate for multi-region deployments and co-development. These partners offer channel access in the US, Australia, and Qatar, presenting joint bids for water utilities, government projects, and university-led pilots.

Funding Momentum Funding momentum and strategic grants signal capacity to scale go-to-market efforts. With early-stage revenue and a lean team, opportunities exist to expand distributor networks, run pilots with water utilities and pharmaceutical QA labs, and leverage the sustainability-focused value proposition to win long-term contracts.

Similar companies to bNovate Technologies SA

bNovate Technologies SA Tech Stack

bNovate Technologies SA uses 8 technology products and services including Google Cloud CDN, Wix, RSS, and more. Explore bNovate Technologies SA's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Wix
    Content Management System
  • RSS
    Content Management System
  • Module Federation
    Development
  • Wix eCommerce
    E-commerce
  • Google Workspace
    Email
  • Lodash
    Javascript Libraries
  • FlippingBook
    Widgets

Media & News

bNovate Technologies SA's Email Address Formats

bNovate Technologies SA uses at least 1 format(s):
bNovate Technologies SA Email FormatsExamplePercentage
First.Last@bnovate.comJohn.Doe@bnovate.com
100%

Frequently Asked Questions

What is bNovate Technologies SA's official website and social media links?

Minus sign iconPlus sign icon
bNovate Technologies SA's official website is bnovate.com and has social profiles on LinkedInCrunchbase.

What is bNovate Technologies SA's SIC code NAICS code?

Minus sign iconPlus sign icon
bNovate Technologies SA's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does bNovate Technologies SA have currently?

Minus sign iconPlus sign icon
As of July 2026, bNovate Technologies SA has approximately 45 employees across 2 continents, including EuropeAsia. Key team members include Chief Executive Officer: S. G.Cto: L. G.Coo: D. W.. Explore bNovate Technologies SA's employee directory with LeadIQ.

What industry does bNovate Technologies SA belong to?

Minus sign iconPlus sign icon
bNovate Technologies SA operates in the Biotechnology Research industry.

What technology does bNovate Technologies SA use?

Minus sign iconPlus sign icon
bNovate Technologies SA's tech stack includes Google Cloud CDNWixRSSModule FederationWix eCommerceGoogle WorkspaceLodashFlippingBook.

What is bNovate Technologies SA's email format?

Minus sign iconPlus sign icon
bNovate Technologies SA's email format typically follows the pattern of First.Last@bnovate.com. Find more bNovate Technologies SA email formats with LeadIQ.

How much funding has bNovate Technologies SA raised to date?

Minus sign iconPlus sign icon
As of July 2026, bNovate Technologies SA has raised $23M in funding. The last funding round occurred on Feb 21, 2025 for $4.2M.

When was bNovate Technologies SA founded?

Minus sign iconPlus sign icon
bNovate Technologies SA was founded in 2011.
bNovate Technologies SA logo

bNovate Technologies SA

Biotechnology ResearchVaud, Switzerland11-50 Employees

bNovate Technologies SA is a Swiss biotechnology company focused on rapid microbiological monitoring for pharmaceutical production and drinking water. Its instruments use automated flow cytometry to deliver microbial results in about 20 minutes, a fraction of the time required by traditional methods.

Based in Ecublens, Vaud, the company operates with a small to mid-sized team. Its customers include pharmaceutical manufacturers and drinking water providers seeking timely, reliable microbial quality data. In June 2026 the company expanded its U.S. presence and formed an agreement with Best Water Science to broaden real-time water monitoring in the United States.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $23M

    bNovate Technologies SA has raised a total of $23M of funding over 5 rounds. Their latest funding round was raised on Feb 21, 2025 in the amount of $4.2Mas a grant.

  • $1M

    bNovate Technologies SA's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $23M

    bNovate Technologies SA has raised a total of $23M of funding over 5 rounds. Their latest funding round was raised on Feb 21, 2025 in the amount of $4.2Mas a grant.

  • $1M

    bNovate Technologies SA's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.